Friday
SESSION 29: ADVANCES IN MEDICAL THERAPY OR TREATMENT OF MEDICAL PROBLEMS OR COMPLICATIONS (5-MINUTE TALKS)
Moderators:Anton N. Sidawy, MD, MPH / Plinio Rossi, MD  
SESSION 29 SCHEDULE
10:45 AM - 10:50 AM Platelet Activity And Optimizing Antiplatelet Treatment: The Next Frontier In Vascular Disease Management
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
10:51 AM - 10:56 AM What’s New With Endovascular Ablation Procedures For Atrial And Ventricular Arrhythmias
  Presenter(s):Larry Chinitz, MD  
10:57 AM - 11:02 AM Why Do Statins Decrease Preoperative And Periprocedural Risks: What Is Optimal Drug Dose And Timing
  Presenter(s):Christos D. Liapis, MD  
  View Abstract      
11:03 AM - 11:08 AM What’s All This Hoopla About Statins And Mental Fogginess, Increased Blood Sugar And Diabetes: Should It Make A Difference In Statin Usage Or Is It A Witch Hunt
  Presenter(s):Don Poldermans, MD  
  View Abstract      
11:09 AM - 11:14 AM New Concepts Regarding The Importance Of Plaque Instability And Stability In Coronary And Vascular Disease: How Instability Should Be Determined And Treated
  Presenter(s):Gregg W. Stone, MD  
11:15 AM - 11:20 AM High Incidence Of Asymptomatic Elevated Troponin Levels (Troponin-Only MIs) After Open Vascular Surgery: What Does It Mean And What Can Be Done To Decrease It
  Presenter(s):Caron B. Rockman, MD  
11:21 AM - 11:26 AM DEBATE: Why We Should Not Stop Screening For Asymptomatic Carotid Stenosis
  Presenter(s):Glenn Jacobowitz, MD  
11:27 AM - 11:32 AM DEBATE: We Should Stop Screening For Asymptomatic Carotid Stenosis Even Though There Is A Substantial Incidence Of Silent Cerebral Events In These Patients: What Should We Do About It
  Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
11:33 AM - 11:38 AM What’s New About The Role Of Cilostazol In Patients With Vascular Disease: What Are Some Of Its Newly Found Benefits
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
11:39 AM - 11:44 AM DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: Yes, It Decreases Risk And Is Cost Effective
  Presenter(s):Don Poldermans, MD  
  View Abstract      
11:45 AM - 11:50 AM DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: No, It Is Too Dangerous; Better To Wait For Symptoms
  Presenter(s):Erich Minar, MD  
11:51 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break (Americas Hall - 3rd Floor)
Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 29
previous next